Despite the many people praising medications like Ozempic, some are unaware of the potential issues that can arise from ...

FROM sulphur burps to diarrhoea and nausea, there are many widely known Ozempic side effects – but there’s also a whole host of nasty long-term issues experts are only just uncovering.

There is no evidence that Ozempic or other GLP-1 drugs increase the risk of pancreatic cancer. In fact, the opposite may be true. Real-world data, covering the experiences of hundreds of thousands ...

Popular GLP-1 weight-loss drugs like Ozempic and Zepbound can help reduce a woman's risk for as many as 14 cancers associated ...

A doctor has warned of the 'multitude of factors' which could risk any long-term results once someone stops taking Ozempic.

An Ozempic Expert Explains What You Need to Know ... finding a difference and others not finding a difference in cancer risk—seemed to come from the fact that some studies do what we did ...

Saxenda and Ozempic have a boxed warning for risk of thyroid cancer. A boxed warning is a serious warning from the FDA. To learn more, see the “Precautions for Saxenda and Ozempic” section.

Mounjaro, Ozempic and other fat-melting injections ... no medications have been proven to lower the cancer risk associated with obesity. 'Our study begins to fill that gap by evaluating GLP ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

Based on animal studies, it’s thought that Ozempic may increase your risk of thyroid cancer. It’s important to note that animal studies don’t always predict what will happen in humans.

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).